ALHC - NASDAQ

Alignment Healthcare, Inc.

Alignment Healthcare, Inc.

ALHC·NASDAQ

$14.25

+7.1%
HealthcareMedical - Healthcare Plans

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$2.95B
EPS-0.0037
P/E Ratio-3851.35
Earnings Date07/30/2026
139.93M
Operating Cash Flow
302%
3Y-408.0%
5Y+1751.0%
10Y+1420.0%
-14.97M
Investing Cash Flow
-138%
3Y-47.0%
5Y-8.0%
10Y+46.0%
18.04M
Financing Cash Flow
-88%
3Y+9.0%
5Y-86.0%
10Y-66.0%
ALHC

Alignment Healthcare, Inc. Cash Conversion Engine

ALHC · NASDAQ
Net Income-724.00K
Depreciation & Amortization30.48M
Stock-Based Compensation62.08M
Change in Working Capital45.51M
Others2.58M
Capital Expenditures-26.78M
Free Cash Flow113.15M

Cash Flow Quality Analysis

FCF Conversion Rate

-15627.9%

Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.

CapEx Intensity

19.1%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+1802.0%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

+$45.51M

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

Alignment Healthcare, Inc. Cash Flow Statement

ALHC • NASDAQ

Alignment Healthcare, Inc. Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
OPERATING ACTIVITIES
Net Income
-724K
-128.1M
-148.2M
-149.6M
-195.3M
-22.9M
-44.7M
Depreciation & Amortization
30.5M
27.1M
21.7M
17.5M
16M
15.5M
16.6M
Stock-Based Compensation
62.1M
71.1M
66.8M
81.7M
110.6M
2.1M
1.2M
Other Non-Cash Items
2.6M
3.8M
-1.5M
10.6M
9.3M
9.6M
7.2M
Change in Working Capital
45.5M
60.9M
2M
-5.6M
-19.4M
3.3M
29M
Cash from Operating Activities
139.9M
34.8M
-59.2M
-45.4M
-78.8M
7.6M
9.2M
INVESTING ACTIVITIES
Investments in Property, Plant, and Equipment
-26.8M
-41.4M
-36M
-23.8M
-18.4M
-15.7M
-10.2M
Acquisitions, Net
(1.1M)
(0.0)
(0.0)
-4M
(0.0)
(0.0)
(0.0)
Purchase of Investments
-65.6M
-82.2M
-379.1M
-2.8M
-2.5M
-1.6M
-320K
Sale/Maturity of Investments
76.3M
162.8M
267.8M
2.4M
1.4M
825K
325K
Other Investing Items
0.0
14K
0.0
0.0
-1.4M
100K
0.0
Cash from Investing Activities
-15M
(39.2M)
-147.3M
-28.2M
-20.8M
-16.4M
-10.2M
FINANCING ACTIVITIES
Net Issuance of Common Stock
18.1M
-350K
0.0
0.0
389.1M
133.5M
-1.5M
Net Issuance of Debt
0.0
165M
0.0
21.8M
0.0
0.0
55M
Share Repurchases
(0.0)
-350K
(0.0)
(0.0)
-1.5M
-1.5M
-2M
Other Financing Items
-26K
-8.6M
105K
-5.2M
-29M
-3.4M
-854K
Cash from Financing Activities
18M
156M
105K
16.6M
360.1M
130.1M
52.7M
CASH FLOW SUMMARY
Net Change in Cash
143M
230M
-206.3M
-57.1M
260.5M
121.3M
51.6M
Cash at Beginning of Period
434.9M
205M
411.3M
468.4M
207.8M
86.5M
34.9M
Cash at End of Period
577.9M
434.9M
205M
411.3M
468.4M
207.8M
86.5M
Free Cash Flow
113.1M
-6.6M
-95.2M
-69.2M
-97.1M
-8.1M
-1M

SEC Filings

ALHC - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
8-K

8-K 2026

N/A

May 12, 2026
May 06, 2026
2026
View Filing
10-Q

10-Q 2026 Q1

Q1

April 30, 2026
March 31, 2026
2026
View Filing
8-K

8-K 2026

N/A

April 30, 2026
April 30, 2026
2026
View Filing
DEF 14A

DEF 14A 2026

N/A

April 24, 2026
June 04, 2026
2026
View Filing
8-K

8-K 2026

N/A

March 04, 2026
March 02, 2026
2026
View Filing
10-K

10-K 2025 FY

FY

February 27, 2026
December 31, 2025
2025
View Filing
8-K

8-K 2026

N/A

February 26, 2026
February 26, 2026
2026
View Filing
8-K

8-K 2026

N/A

January 12, 2026
January 12, 2026
2026
View Filing
10-Q

10-Q 2025 Q3

Q3

October 30, 2025
September 30, 2025
2025
View Filing
8-K

8-K 2025

N/A

October 30, 2025
October 30, 2025
2025
View Filing
Showing 1 to 10 of 82 filings

Related Guides

Blog Categories

Continue your ALHC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.